Skip to main content
. 2022 Jan 11;12:796704. doi: 10.3389/fneur.2021.796704

Table 1.

MicroRNAs therapy.

MicroRNA Source and methodologies Effects
MiR-133b Extraneous: lentiviral delivery Downregulate the expression of chondroitin sulfate proteoglycans, RhoA and inhibit microglia/macrophage proliferation (115)
MiR-124 Extraneous: cell transfection Reduced proinflammatory molecules (116)
MiR-873a-5p Endogenous: astrocyte-derived exosomes Reduce inflammatory cytokines, increase anti-inflammatory factors (117)
MiR-34a Extraneous: intrathecal injection Reduce inflammatory cytokines secretion of microglia, promote neural recovery and locomotor function (118)
MiR-150 Extraneous: cell transfection Decrease the expression of pro-inflammatory cytokines (119)
MiR-216a-5p Endogenous: MSC-derived exosomes Switching microglial phenotype to secret anti-inflammatory molecules (111)
MiR-340-5p Extraneous: cell transfection Attenuate inflammation, oxidative stress, and apoptosis (120)
MiR-23b Extraneous: cell transfection Inhibited the BV-2 cells apoptosis and NF-κB activation (121)
MiR-193a antagomir Extraneous: cell transfection Reduced expression of neuroinflammatory molecules (122)
miR-429 inhibitors Extraneous: cell transfection Reduced expression of neuroinflammatory molecules (123)
MiR-223-5p inhibitor Extraneous: intrathecal injection Reduced expression of neuroinflammatory molecules, reduced neuron apoptosis and promoted locomotor recovery (124)
MiR27a Extraneous: cell transfection Alleviate apoptosis and inflammatory injury (125)
MiR100 Extraneous: cell transfection and intrathecal injection Suppresses microglia activation and neuronal apoptosis (126)
MiR-183 Extraneous: intracerebroventrivular injection Inhibits microglia activation and expression of inflammatory factors (127)